LexDanaLexDanabeta
Inventor

Robert KUEHL

Inventor
US

Overview

4→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07BGeneral methods of organic chemistry21%
C07DHeterocyclic compounds21%
PatentTitleYear
12,551,448Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor202612,275,704Heterocyclic compounds and their uses202511,884,630Heterocyclic compounds and their uses202411,384,053Heterocyclic compounds and their uses2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to CYTOKINETICS INC (3)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to PHARMACYCLICS LLC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CYTOKINETICS INC32022–2025
PHARMACYCLICS LLC12026
Locations
LocationPatentsSpan
US42022–2026